Science & Technology

Raising cash for bioscience with Trevor Martin (Mammoth Biosciences) + Ursheet Parikh (Mayfield)

Trevor Martin started Mammoth Biosciences with the goal of using the revolutionary technology CRISPR to diagnose and cure diseases. The Stanford grad raised $268.12M to advance this goal, but like so many other companies, it all started at an accelerator. Hear from Martin and early investor, Ursheet Parikh on how Mammoth Biosciences secured early financing…

Published

2 years ago

on

Trevor Martin started Mammoth Biosciences with the goal of using the revolutionary technology CRISPR to diagnose and cure diseases. The Stanford grad raised $268.12M to advance this goal, but like so many other companies, it all started at an accelerator. Hear from Martin and early investor, Ursheet Parikh on how Mammoth Biosciences secured early financing and won the support of Mayfield and CRISPR-co-inventor Jennifer Doudna.

Related Topics:

1 Comment

  1. Sean W

    October 6, 2022 at 1:27 am

    At what stage will Mammoth look to go public? Many biotechs go public well before they have a product in the marketplace. Does Mammoth feel they need to have a certain level of revenue before going public?

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version